Forecasts data is unavailable for this security.
Share price forecast
The 2 analysts offering 12 month price targets for Eliem Therapeutics Inc have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a -45.65% decrease from the last price of 8.28.
High | -39.6% | 5.00 |
Med | -45.7% | 4.50 |
Low | -51.7% | 4.00 |
Earnings history & estimates in USD
Average growth rate | +59.43% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
More ▼